Clinical Trial Update: Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

View source ↗

Summary

This clinical trial is evaluating hydroxyurea exposure during pregnancy and lactation in people with sickle cell disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Sickle Cell Disease, Sickle Cell Anemia | Status: RECRUITING